{"id":"https://openalex.org/W2997776115","doi":"https://doi.org/10.2174/1573406416666191227123048","title":"Antidiabetic Activity of Dihydropyrimidine Scaffolds and Structural Insight by Single Crystal X-ray Studies","display_name":"Antidiabetic Activity of Dihydropyrimidine Scaffolds and Structural Insight by Single Crystal X-ray Studies","publication_year":2019,"publication_date":"2019-12-27","ids":{"openalex":"https://openalex.org/W2997776115","doi":"https://doi.org/10.2174/1573406416666191227123048","mag":"2997776115","pmid":"https://pubmed.ncbi.nlm.nih.gov/31880253"},"language":"en","primary_location":{"id":"doi:10.2174/1573406416666191227123048","doi":"https://doi.org/10.2174/1573406416666191227123048","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1573406416666191227123048","pdf_url":null,"source":{"id":"https://openalex.org/S155723790","display_name":"Medicinal Chemistry","issn_l":"1573-4064","issn":["1573-4064","1875-6638"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056340736","display_name":"Keshab M. Bairagi","orcid":"https://orcid.org/0000-0002-7996-9601","observed_orcids":["https://orcid.org/0000-0002-7996-9601"]},"institutions":[{"id":"https://openalex.org/I167153416","display_name":"Visvesvaraya National Institute of Technology","ror":"https://ror.org/02zrtpp84","country_code":"IN","type":"education","lineage":["https://openalex.org/I167153416"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Keshab M. Bairagi","raw_affiliation_strings":["Department of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, India"],"raw_orcid":"https://orcid.org/0000-0002-7996-9601","affiliations":[{"raw_affiliation_string":"Department of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, India","institution_ids":["https://openalex.org/I167153416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047703614","display_name":"Nancy S. Younis","orcid":"https://orcid.org/0000-0003-4309-7095","observed_orcids":["https://orcid.org/0000-0003-4309-7095"]},"institutions":[{"id":"https://openalex.org/I4626487","display_name":"King Faisal University","ror":"https://ror.org/00dn43547","country_code":"SA","type":"education","lineage":["https://openalex.org/I4626487"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Nancy S. Younis","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0003-4309-7095","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia","institution_ids":["https://openalex.org/I4626487"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049998061","display_name":"Promise Madu Emeka","orcid":"https://orcid.org/0000-0003-1943-1874","observed_orcids":["https://orcid.org/0000-0003-1943-1874"]},"institutions":[{"id":"https://openalex.org/I4626487","display_name":"King Faisal University","ror":"https://ror.org/00dn43547","country_code":"SA","type":"education","lineage":["https://openalex.org/I4626487"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Promise M. Emeka","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0003-1943-1874","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia","institution_ids":["https://openalex.org/I4626487"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079636411","display_name":"Ekta Sangtani","orcid":"https://orcid.org/0000-0001-7370-623X","observed_orcids":["https://orcid.org/0000-0001-7370-623X"]},"institutions":[{"id":"https://openalex.org/I3125981224","display_name":"National Chemical Laboratory","ror":"https://ror.org/057mn3690","country_code":"IN","type":"facility","lineage":["https://openalex.org/I2799351866","https://openalex.org/I3125981224","https://openalex.org/I4210134808","https://openalex.org/I66760702"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ekta Sangtani","raw_affiliation_strings":["Center for Materials Characterisation, CSIR-National Chemical Laboratory, Dr. HomiBhabha Road, Pune 411 008, India"],"raw_orcid":"https://orcid.org/0000-0001-7370-623X","affiliations":[{"raw_affiliation_string":"Center for Materials Characterisation, CSIR-National Chemical Laboratory, Dr. HomiBhabha Road, Pune 411 008, India","institution_ids":["https://openalex.org/I3125981224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074071322","display_name":"Rajesh G. Gonnade","orcid":"https://orcid.org/0000-0002-2841-0197","observed_orcids":["https://orcid.org/0000-0002-2841-0197"]},"institutions":[{"id":"https://openalex.org/I3125981224","display_name":"National Chemical Laboratory","ror":"https://ror.org/057mn3690","country_code":"IN","type":"facility","lineage":["https://openalex.org/I2799351866","https://openalex.org/I3125981224","https://openalex.org/I4210134808","https://openalex.org/I66760702"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rajesh G. Gonnade","raw_affiliation_strings":["Center for Materials Characterisation, CSIR-National Chemical Laboratory, Dr. HomiBhabha Road, Pune 411 008, India"],"raw_orcid":"https://orcid.org/0000-0002-2841-0197","affiliations":[{"raw_affiliation_string":"Center for Materials Characterisation, CSIR-National Chemical Laboratory, Dr. HomiBhabha Road, Pune 411 008, India","institution_ids":["https://openalex.org/I3125981224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011098931","display_name":"Katharigatta Narayanaswamy Venugopala","orcid":"https://orcid.org/0000-0003-0680-1549","observed_orcids":["https://orcid.org/0000-0003-0680-1549"]},"institutions":[{"id":"https://openalex.org/I4626487","display_name":"King Faisal University","ror":"https://ror.org/00dn43547","country_code":"SA","type":"education","lineage":["https://openalex.org/I4626487"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Katharigatta N. Venugopala","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0003-0680-1549","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia","institution_ids":["https://openalex.org/I4626487"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053628572","display_name":"Osama I. Alwassil","orcid":"https://orcid.org/0000-0002-6572-8321","observed_orcids":["https://orcid.org/0000-0002-6572-8321"]},"institutions":[{"id":"https://openalex.org/I185203018","display_name":"King Saud bin Abdulaziz University for Health Sciences","ror":"https://ror.org/0149jvn88","country_code":"SA","type":"education","lineage":["https://openalex.org/I185203018"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Osama I. Alwassil","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0002-6572-8321","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia","institution_ids":["https://openalex.org/I185203018"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016992081","display_name":"Hany Ezzat Khalil","orcid":"https://orcid.org/0000-0001-7892-3380","observed_orcids":["https://orcid.org/0000-0001-7892-3380"]},"institutions":[{"id":"https://openalex.org/I4626487","display_name":"King Faisal University","ror":"https://ror.org/00dn43547","country_code":"SA","type":"education","lineage":["https://openalex.org/I4626487"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Hany E. Khalil","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0001-7892-3380","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia","institution_ids":["https://openalex.org/I4626487"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041907165","display_name":"Susanta Kumar Nayak","orcid":"https://orcid.org/0000-0002-3175-9007","observed_orcids":["https://orcid.org/0000-0002-3175-9007"]},"institutions":[{"id":"https://openalex.org/I167153416","display_name":"Visvesvaraya National Institute of Technology","ror":"https://ror.org/02zrtpp84","country_code":"IN","type":"education","lineage":["https://openalex.org/I167153416"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Susanta K. Nayak","raw_affiliation_strings":["Department of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, India"],"raw_orcid":"https://orcid.org/0000-0002-3175-9007","affiliations":[{"raw_affiliation_string":"Department of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, India","institution_ids":["https://openalex.org/I167153416"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5011098931","https://openalex.org/A5041907165"],"corresponding_institution_ids":["https://openalex.org/I167153416","https://openalex.org/I4626487"],"apc_list":null,"apc_paid":null,"fwci":0.6519,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.54731027,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"16","issue":"7","first_page":"996","last_page":"1003"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7890999913215637,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7890999913215637,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.09059999883174896,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.053199999034404755,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dihydropyrimidine-derivatives","display_name":"dihydropyrimidine derivatives","score":0.902999997138977},{"id":"https://openalex.org/keywords/antidiabetic-activity","display_name":"antidiabetic activity","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hypoglycemic-activity","display_name":"hypoglycemic activity","score":0.949999988079071},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.9240000247955322},{"id":"https://openalex.org/keywords/tetrahydropyrimidines","display_name":"tetrahydropyrimidines","score":0.7689999938011169},{"id":"https://openalex.org/keywords/urea-derivatives","display_name":"urea derivatives","score":0.597000002861023},{"id":"https://openalex.org/keywords/thiourea-derivatives","display_name":"thiourea derivatives","score":0.9900000095367432},{"id":"https://openalex.org/keywords/substituent-effects","display_name":"substituent effects","score":0.5809999704360962},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.7059999704360962},{"id":"https://openalex.org/keywords/supramolecular-interactions","display_name":"supramolecular interactions","score":0.9039999842643738},{"id":"https://openalex.org/keywords/blood-glucose","display_name":"blood glucose","score":0.47200000286102295},{"id":"https://openalex.org/keywords/nicotinamide","display_name":"nicotinamide","score":0.6460000276565552},{"id":"https://openalex.org/keywords/gliclazide","display_name":"gliclazide","score":0.8769999742507935},{"id":"https://openalex.org/keywords/diabetes-management","display_name":"diabetes management","score":0.421999990940094},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C2778689049","wikidata":"https://www.wikidata.org/wiki/Q898422","display_name":"Substituent","level":2,"score":0.8216992616653442},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6621671915054321},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.642901599407196},{"id":"https://openalex.org/C2780538656","wikidata":"https://www.wikidata.org/wiki/Q528995","display_name":"Thiourea","level":2,"score":0.5850543975830078},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.5628840923309326},{"id":"https://openalex.org/C90150868","wikidata":"https://www.wikidata.org/wiki/Q39513","display_name":"Alkoxy group","level":3,"score":0.48799461126327515},{"id":"https://openalex.org/C2778074193","wikidata":"https://www.wikidata.org/wiki/Q3498942","display_name":"Carboxylate","level":2,"score":0.47940918803215027},{"id":"https://openalex.org/C2780365088","wikidata":"https://www.wikidata.org/wiki/Q48318","display_name":"Urea","level":2,"score":0.4733426868915558},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.42081621289253235},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.225515216588974},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1336773931980133},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.08141475915908813},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.061821967363357544},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013311","descriptor_name":"Streptozocin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1573406416666191227123048","doi":"https://doi.org/10.2174/1573406416666191227123048","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1573406416666191227123048","pdf_url":null,"source":{"id":"https://openalex.org/S155723790","display_name":"Medicinal Chemistry","issn_l":"1573-4064","issn":["1573-4064","1875-6638"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:31880253","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31880253","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal chemistry (Shariqah (United Arab Emirates))","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4838959846","display_name":null,"funder_award_id":"98884","funder_id":"https://openalex.org/F4320320671","funder_display_name":"National Research Foundation"},{"id":"https://openalex.org/G54308155","display_name":null,"funder_award_id":"ECR/2016/-001820","funder_id":"https://openalex.org/F4320334771","funder_display_name":"Science and Engineering Research Board"},{"id":"https://openalex.org/G8647902677","display_name":null,"funder_award_id":"96807","funder_id":"https://openalex.org/F4320320671","funder_display_name":"National Research Foundation"}],"funders":[{"id":"https://openalex.org/F4320320671","display_name":"National Research Foundation","ror":"https://ror.org/05s0g1g46"},{"id":"https://openalex.org/F4320334771","display_name":"Science and Engineering Research Board","ror":"https://ror.org/03ffdsr55"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1556097100","https://openalex.org/W1567464438","https://openalex.org/W1963664975","https://openalex.org/W1969360633","https://openalex.org/W1972493784","https://openalex.org/W1976210279","https://openalex.org/W1978633893","https://openalex.org/W1979368277","https://openalex.org/W1985062311","https://openalex.org/W1990170643","https://openalex.org/W1999677080","https://openalex.org/W2008837037","https://openalex.org/W2012488984","https://openalex.org/W2024175762","https://openalex.org/W2052664835","https://openalex.org/W2055011154","https://openalex.org/W2066647351","https://openalex.org/W2067294686","https://openalex.org/W2075983065","https://openalex.org/W2089319980","https://openalex.org/W2112219711","https://openalex.org/W2119304571","https://openalex.org/W2155326729","https://openalex.org/W2293779812","https://openalex.org/W2319902168","https://openalex.org/W2513270693","https://openalex.org/W2561146307","https://openalex.org/W2596847555","https://openalex.org/W2689579208","https://openalex.org/W2766900411","https://openalex.org/W2801352359","https://openalex.org/W2808783624","https://openalex.org/W2951325173","https://openalex.org/W2953033623","https://openalex.org/W4241161331","https://openalex.org/W4244464832"],"related_works":["https://openalex.org/W3092395821","https://openalex.org/W4403968984","https://openalex.org/W7165061869","https://openalex.org/W3138221856","https://openalex.org/W4322761874","https://openalex.org/W2318975858","https://openalex.org/W7095119280","https://openalex.org/W1517490284","https://openalex.org/W4412675752","https://openalex.org/W2010508025"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"research":[2],"project":[3],"is":[4],"designed":[5],"to":[6,16,136,176,348],"identify":[7],"the":[8,12,18,109,118,122,133,137,153,177,181,190,214,244,250,264,328,337],"anti-diabetic":[9],"effects":[10],"of":[11,20,25,36,96,149,243,259,287,317,344],"newly":[13,66,97,251],"synthesized":[14,51,67,119,252,318,329],"compounds":[15,29,68,155,179,254,319],"conclude":[17],"perspective":[19],"consuming":[21],"one":[22],"or":[23],"more":[24],"these":[26,305],"new":[27,330],"synthetic":[28],"for":[30,54,189,268,285,311],"diabetes":[31,292],"management.":[32],"INTRODUCTION:":[33],"A":[34],"series":[35],"dihydropyrimidine":[37,253],"(DHPM)":[38],"derivative":[39,145,332],"bearing":[40],"electron":[41],"releasing":[42],"and":[43,52,77,84,115,142,159,165,221,233,279,289],"electron-withdrawing":[44],"substituent's":[45],"on":[46,58,104,108,129,168,336],"phenyl":[47,110,130,169,338],"ring":[48,111,131,139,170,339],"(a-j)":[49],"were":[50,69,87,192,203,212,227,247,298,320],"screened":[53],"antihyperglycemic(":[55],"anti-diabetic)":[56],"activity":[57,94,174],"streptozotocin":[59,215],"(STZ)":[60],"induced":[61],"diabetic":[62,217,225,245],"rat":[63,187],"model.":[64],"The":[65,81,185,240,272,307],"characterized":[70],"by":[71],"using":[72,263],"FT-IR,":[73],"melting":[74],"point,":[75],"1H":[76],"13C":[78],"NMR":[79],"analysis.":[80],"crystal":[82],"structure":[83],"supramolecular":[85],"features":[86],"analyzed":[88],"through":[89],"single-crystal":[90],"X-ray":[91],"study.":[92],"Anti-diabetic":[93],"testing":[95],"prepared":[98],"DHPM":[99,120,331],"scaffolds":[100],"was":[101,276,313],"mainly":[102],"based":[103],"their":[105],"relative":[106],"substituent":[107],"along":[112],"with":[113,140,205,229,249,304],"urea":[114,141],"thiourea.":[116],"Among":[117],"scaffold,":[121],"test":[123],"compound":[124],"c":[125],"having":[126,163],"chlorine":[127],"group":[128,200,210,219,223,335],"at":[132],"ortho":[134],"position":[135],"hydropyrimidine":[138],"methyl":[143,156],"acetoacetate":[144],"shows":[146,340],"moderate":[147],"lowering":[148,343],"glucose":[150,274,296,345],"level.":[151],"However,":[152],"title":[154],"4-(4-hydroxy-3-methoxyphenyl)-":[157],"6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate(g)":[158],"ethyl":[160],"4-(3-ethoxy-4-":[161],"hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate(h)":[162],"methoxy":[164],"ethoxy":[166],"substituents":[167],"show":[171],"significant":[172,342],"hypoglycemic":[173],"compared":[175,347],"remaining":[178,241],"from":[180],"Scheme":[182],"1.":[183],"METHODS:":[184],"experimental":[186],"models":[188],"study":[191],"divided":[193],"into":[194],"13":[195],"groups":[196,242],"(n":[197],"=":[198],"10);":[199],"1":[201],"animals":[202,226,246],"treated":[204],"0.5%":[206],"CMC":[207],"(0.5mL)":[208],"(vehicle);":[209],"2":[211,291],"considered":[213],"(STZ)/nicotinamide":[216],"control":[218],"(DC)":[220],"untreated,":[222],"3":[224],"administered":[228,248],"gliclazide":[230,312],"50":[231,260],"mg/kg":[232,261],"act":[234],"as":[235],"a":[236,256,341],"reference":[237],"drug":[238],"group.":[239],"in":[255],"single":[257],"dose":[258],"orally":[262],"oral":[265],"gavage,":[266],"daily":[267],"7":[269],"days":[270],"continuously.":[271],"blood":[273],"level":[275,346],"measured":[277],"before":[278],"72":[280],"hrs":[281],"after":[282,302],"nicotinamide-STZ":[283],"injection,":[284],"confirmation":[286],"hyperglycemia":[288],"type":[290],"development.":[293],"RESULTS:":[294],"Blood":[295],"levels":[297],"significantly":[299],"(p<0.05)":[300],"reduced":[301],"treatment":[303],"derivatives.":[306,350],"mean":[308],"percentage":[309],"reduction":[310],"50%,":[314],"while":[315],"that":[316,327],"approximately":[321],"36%.":[322],"CONCLUSION:":[323],"Our":[324],"result":[325],"suggests":[326],"containing":[333],"alkoxy":[334],"other":[349]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-01-10T00:00:00"}
